Publikationen, an denen er mitarbeitet Ginés Luengo Gil (1)

2023

  1. Venetoclax is a potent hepsin inhibitor that reduces the metastatic and prothrombotic phenotypes of hepsin-expressing colorectal cancer cells

    Frontiers in Molecular Biosciences, Vol. 10